SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-18-000022
Filing Date
2018-07-26
Accepted
2018-07-26 16:08:10
Documents
94
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2018q210-q.htm 10-Q 1846416
2 EXHIBIT 3.1 a2018q210-qexhibit31.htm EX-3.1 313735
3 EXHIBIT 3.2 a2018q210-qexhibit32.htm EX-3.2 102577
4 EXHIBIT 31.1 a2018q210-q_exhibit311.htm EX-31.1 14548
5 EXHIBIT 31.2 a2018q210-q_exhibit312.htm EX-31.2 14382
6 EXHIBIT 32.1 a2018q210-q_exhibit321.htm EX-32.1 11896
  Complete submission text file 0000875320-18-000022.txt   11042868

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vrtx-20180630.xml EX-101.INS 2740142
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20180630.xsd EX-101.SCH 69792
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20180630_cal.xml EX-101.CAL 109313
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20180630_def.xml EX-101.DEF 428135
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20180630_lab.xml EX-101.LAB 815463
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20180630_pre.xml EX-101.PRE 565316
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 18971827
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1